StockData
Guardian Pharmacy Services, Inc. logo

Guardian Pharmacy Services, Inc. (GRDN) stock

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30157% above fair value
$49.38−0.60 (-1.20%)

Close on Nov 12, 2026Market cap $3.13BP/E –Yield –

Earnings

Guardian Pharmacy Services's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 10, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$371.10M
-1.7% on a year earlier
Adjusted EPS, Q3 FY2026
$0.33
Latest guidance
Raised
Nov 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Guardian Pharmacy Services's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 10, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$371.10M-1.7%$0.29$0.33Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026during market hours$351.80M+2.2%$0.34$0.29Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours$336.60M+2.2%$0.21$0.29Release
Q4 FY2025ended Dec 31, 2025Mar 11, 2026during market hours$397.60M+17.4%$0.33$0.37Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025during market hours$377.40M+20.0%––Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025during market hours$344.30M–$0.14$0.23Release
Q1 FY2025ended Mar 31, 2025May 12, 2025during market hours$329.30M–$0.15–Release
Q4 FY2024ended Dec 31, 2024Mar 26, 2025during market hours$338.60M–$0.19–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024during market hours$314.40M–-$2.00–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Guardian Pharmacy Services's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueGAAPFY2026$1.44B – $1.46B$1.40B – $1.42BRaisedNov 5, 2026
RevenueFY2026$1.43B – $1.45B$1.40B – $1.42BRaisedAug 6, 2026
Adjusted EBITDAnon-GAAPFY2026$136.00M – $138.00M$120.00M – $124.00MRaisedNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$129.00M – $131.00M$123.00M – $127.00MRaisedAug 6, 2026

Guidance vs results

The last range Guardian Pharmacy Services gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$1.43B – $1.45B$1.45BΣ4QWithin range

Guidance history

Every forecast Guardian Pharmacy Services put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDAFY2026$136.00M – $138.00MRaised
Nov 5, 2026RevenueFY2026$1.44B – $1.46BRaised
Aug 6, 2026Adjusted EBITDAFY2026$129.00M – $131.00MRaised
Aug 6, 2026RevenueFY2026$1.43B – $1.45BRaised
May 6, 2026Adjusted EBITDAFY2026$123.00M – $127.00MRaised
May 6, 2026RevenueFY2026$1.40B – $1.42BReaffirmed
Mar 11, 2026Adjusted EBITDAFY2026$120.00M – $124.00MNew
Mar 11, 2026RevenueFY2026$1.40B – $1.42BNew
Jan 13, 2026adjusted EBITDAFY2025$104.00M – $106.00MReaffirmed
Jan 13, 2026adjusted EBITDAFY2026$115.00M – $118.00MNew
Jan 13, 2026revenueFY2025$1.43B – $1.45BReaffirmed
Jan 13, 2026revenueFY2026$1.40B – $1.42BNew
Nov 10, 2025Adjusted EBITDAFY2025$104.00M – $106.00MNew
Nov 10, 2025RevenueFY2025$1.43B – $1.45BNew
Aug 11, 2025Adjusted EBITDAFY2025$100.00M – $102.00MRaised
Aug 11, 2025RevenueFY2025$1.39B – $1.41BRaised
May 12, 2025Adjusted EBITDAFY2025$97.00M – $101.00MReaffirmed
May 12, 2025RevenueFY2025$1.33B – $1.35BReaffirmed
Mar 26, 2025Adjusted EBITDAFY2025$97.00M – $101.00MReaffirmed
Mar 26, 2025RevenueFY2025$1.33B – $1.35BReaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Guardian Pharmacy Services filed with the SEC as exhibits to Form 8-K or 6-K

  1. Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance
    Results
  2. Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
    Results
  3. Guardian Pharmacy Services, Inc. Announces Leadership Transitions
    Update
  4. Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance
    Results
  5. Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026
    Results
  6. Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
    Results
  7. Smarter Growth, Better Service January
    Results
  8. Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance
    Results
  9. 8-K exhibit EX-99.1
    Update
  10. Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
    Results
  11. 8-K exhibit EX-99.1
    Update
  12. Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results
    Results
  13. Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
    Results
  14. Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results;
    Results
  15. Disclaimer This presentation has been prepared by Guardian Pharmacy
    Results

See a number that looks wrong?